Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE for ABILIFY ASIMTUFII at AbilifyAsimtufii.com and ABILIFY MAINTENA
INDICATIONS and IMPORTANT SAFETY INFORMATION for ABILIFY ASIMTUFII (aripiprazole) and ABILIFY MAINTENA (aripiprazole). INDICATIONS: ABILIFY ASIMTUFII is a
Abilify (aripiprazole) [prescribing information]. Rockville, MD: Otsuka America Pharmaceutical Inc; November 2024. Abilify Asimtufii (aripiprazole) [prescribing
HIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII (aripiprazole) extended-release injectable suspension, for intramuscular use . Initial U.S. Approval: 2024
This page provides basic information to guide the prescribing of Abilify Asimtufii.
INDICATIONS and IMPORTANT SAFETY INFORMATION for ABILIFY ASIMTUFII (aripiprazole) and ABILIFY MAINTENA (aripiprazole) ABILIFY ASIMTUFII is a prescription
These highlights do not include all the information needed to use ABILIFY ASIMTUFII safely and effectively. See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII (aripiprazole) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2024
Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE for ABILIFY ASIMTUFII at AbilifyAsimtufii.com and ABILIFY MAINTENA
See full prescribing information for ABILIFY ASIMTUFII. ABILIFY ASIMTUFII (aripiprazole) extended-release injectable suspension, for intramuscular use. Initial
Comments